Featured
-
-
Clinical Study
| Open AccessPrognostic significance of circumferential resection margin involvement following oesophagectomy for cancer and the predictive role of endoluminal ultrasonography
- T D Reid
- , D S Y Chan
- & W G Lewis
-
Epidemiology
| Open AccessEthnicity in relation to incidence of oesophageal and gastric cancer in England
- V H Coupland
- , J Lagergren
- & R H Jack
-
Genetics and Genomics
| Open AccessThe FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma
- M Dibb
- , N Han
- & A D Sharrocks
-
Epidemiology
| Open AccessHookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India
- N A Dar
- , G A Bhat
- & P Boffetta
-
Clinical Study
| Open AccessRPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma
- J Kurashige
- , M Watanabe
- & H Baba
-
Epidemiology
| Open AccessGastric atrophy and oesophageal squamous cell carcinoma: possible interaction with dental health and oral hygiene habit
- D Nasrollahzadeh
- , R Malekzadeh
- & W Ye
-
Epidemiology
| Open AccessReproductive factors and risk of oesophageal cancer, a population-based nested case–control study in Sweden
- Y Lu
- & J Lagergren
-
Molecular Diagnostics
| Open AccessmRNA profiling of the cancer degradome in oesophago–gastric adenocarcinoma
- J P Baren
- , G D Stewart
- & R J E Skipworth
-
Molecular Diagnostics
| Open AccessHigh expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer
- R Hamano
- , H Miyata
- & Y Doki
-
Epidemiology
| Open AccessIncreased risk of laryngeal and pharyngeal cancer after gastrectomy for ulcer disease in a population-based cohort study
- J Lagergren
- & A Lindam
-
Translational Therapeutics
| Open AccessAberrant activation of the mTOR pathway and anti-tumour effect of everolimus on oesophageal squamous cell carcinoma
- K Hirashima
- , Y Baba
- & H Baba
-
Molecular Diagnostics
| Open AccessOverexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma
- H Miyagaki
- , M Yamasaki
- & Y Doki
-
Molecular Diagnostics
| Open AccessPre-treatment plasma proteomic markers associated with survival in oesophageal cancer
- P Kelly
- , F Paulin
- & A Thompson
-
Molecular Diagnostics
| Open AccessThe BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells
- M J Nyhan
- , T R O'Donovan
- & S L McKenna
-
Molecular Diagnostics
| Open AccessThe relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma
- S Dutta
- , J J Going
- & D C McMillan
-
Translational Therapeutics
| Open AccessAdenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effects
- Q Li
- , K Kawamura
- & M Tagawa
-
Molecular Diagnostics
| Open AccessRelative prognostic value of TNM7 vs TNM6 in staging oesophageal cancer
- T D Reid
- , L N Sanyaolu
- & W G Lewis
-
Clinical Study
| Open AccessPhase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
- Z A Wainberg
- , L-S Lin
- & J R Hecht
-
Clinical Study
| Open AccessThe minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma
- C M den Hoed
- , M van Blankenstein
- & E J Kuipers
-
Molecular Diagnostics
| Open AccessCirculating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
- S Komatsu
- , D Ichikawa
- & E Otsuji
-
Epidemiology
| Open AccessCoffee intake and oral–oesophageal cancer: follow-up of 389 624 Norwegian men and women 40–45 years
- A Tverdal
- , V Hjellvik
- & R Selmer
-
Molecular Diagnostics
| Open AccessAbrogated expression of DEC1 during oesophageal squamous cell carcinoma progression is age- and family history-related and significantly associated with lymph node metastasis
- V C L Wong
- , J M Y Ko
- & M L Lung
-
Clinical Study
| Open AccessA multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer
- F De Vita
- , M Orditura
- & F Ciardiello
-
Molecular Diagnostics
| Open AccessRole of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
- M Yamasaki
- , T Makino
- & Y Doki
-
Clinical Study
| Open AccessPhase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer
- F L Day
- , T Leong
- & M Michael
-
Clinical Study
| Open AccessPhase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
- T Conroy
- , Y Yataghène
- & A Adenis
-
Molecular Diagnostics
| Open AccessThymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma
- S Lee
- , Y H Park
- & Y-H Im
-
Epidemiology
| Open AccessSex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma
- M Rutegård
- , H Nordenstedt
- & P Lagergren
-
Short Communication
| Open AccessPrevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey
- Z He
- , Y Zhao
- & Y Ke
-
Molecular Diagnostics
| Open AccessInverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma
- T Maruyama
- , K Mimura
- & K Kono
-
Molecular Diagnostics
| Open AccessDetection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy
- P Kelly
- , V Appleyard
- & A Thompson
-
Translational Therapeutics
| Open AccessTumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy
- K R Fareed
- , A Al-Attar
- & S Madhusudan
-
Molecular Diagnostics
| Open AccessImage cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy
- J M Dunn
- , G D Mackenzie
- & L B Lovat
-
Molecular Diagnostics
| Open AccessPrediction of CCND1 amplification using plasma DNA as a prognostic marker in oesophageal squamous cell carcinoma
- H Takeshita
- , D Ichikawa
- & E Otsuji
-
Clinical Study
| Open AccessPlasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer
- R J E Skipworth
- , D A C Deans
- & K C H Fearon
-
Translational Therapeutics
| Open AccessHuman apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers
- A Al-Attar
- , L Gossage
- & S Madhusudan
-
Clinical Study
| Open AccessRandomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
- N C Tebbutt
- , M M Cummins
- & J Zalcberg